Drug combo doesn’t stem VWD postpartum bleeding, trial finds
Adding Cyklokapron (tranexamic acid) to Vonvendi (recombinant von Willebrand factor) does not appear to reduce blood loss following childbirth for women with von Willebrand…
Von Willebrand disease
FDA expands Vonvendi approval to cover more VWD patients
The U.S. Food and Drug Administration (FDA) has expanded its approval of Vonvendi (recombinant von Willebrand factor), a treatment for von Willebrand disease (VWD).
Research finds bleeding severity varies widely in type 2 VWD
The severity of bleeding in type 2 von Willebrand disease (VWD) can vary widely between subtypes and even among patients who carry the same…
Impacts on quality of life of children with VWD vary based on age
Children with von Willebrand disease (VWD) have reduced health-related quality of life, although the specific areas that seem to be most affected depend on…
New funding will launch trial of tAN for heavy menstrual bleeding
Spark Biomedical has been awarded funding from The Missed Vital Sign, Wellcome Leap’s $50 million program in women’s health, which it will use…
More Haemate-P use could mean big cost savings for Spain: Study
Increasing the use of Haemate-P to treat von Willebrand disease (VWD) could yield substantial savings for the healthcare system in Spain, a study found.
Heavy menstrual bleeding prevalent in women with VWD
About two-thirds of women with von Willebrand disease (VWD) experience heavy menstrual bleeding, according to a study from Sweden. Data also showed that…
Dental procedures may lead to bleeding in VWD, hemophilia
People with von Willebrand disease (VWD) or hemophilia may experience bleeding complications after dental procedures, a new study highlights. Bleeding after such procedures, notably…
Hormonal therapy does not seem to lighten heavy periods in VWD
Hormonal therapy may not be as effective as previously believed to control heavy menstrual bleeding in women with type 1 von Willebrand disease (VWD),…
